Effect of Various Blockers of Arachidonic Acid Metabolism on Release of Beta-Endorphin- and Adrenocorticotropin-Like Immunoreactivity Induced by Phospholipase A2 from Rat Adenohypophysis in vitro

1986 ◽  
Vol 43 (1) ◽  
pp. 44-48 ◽  
Author(s):  
Willhart Knepel ◽  
Gabriele Meyen
Keyword(s):  
Arachidonic Acid ◽  
Acid Metabolism ◽  
Arachidonic Acid Metabolism ◽  
Phospholipase A ◽  
Beta Endorphin

Activity of dipyrone on intraplatelet arachidonic acid metabolism: An in vitro study

1989 ◽  
Vol 21 (1) ◽  
pp. 43-50 ◽  
Author(s):  
R ABBATE ◽  
S PINTO ◽  
A GORI ◽  
R PANICCIA ◽  
M COPPO ◽  
...  
Keyword(s):  
Arachidonic Acid ◽  
Acid Metabolism ◽  
In Vitro Study ◽  
Arachidonic Acid Metabolism ◽  
Vitro Study

scholarly journals Endogenous peroxidase in the nuclear envelope and endoplasmic reticulum of human monocytes in vitro: association with arachidonic acid metabolism

Blood ◽  
1984 ◽  
Vol 64 (2) ◽  
pp. 491-498 ◽  
Author(s):  
W Deimann ◽  
M Seitz ◽  
D Gemsa ◽  
HD Fahimi
Keyword(s):  
Endoplasmic Reticulum ◽  
Protein Synthesis ◽  
Arachidonic Acid ◽  
Nuclear Envelope ◽  
Culture Medium ◽  
Acid Metabolism ◽  
Arachidonic Acid Metabolism ◽  
Substantial Decrease ◽  
Prostaglandin E

Abstract he development of peroxidase (PO) reaction in the nuclear envelope (NE) and endoplasmic reticulum (ER) of monocytes differentiating in vitro and its relationship with arachidonic acid metabolism were studied. The PO, as visualized by the diaminobenzidine (DAB) technique, appeared in the NE and ER of the majority of monocytes within 24 hours of culture, with a substantial decrease thereafter. The influence of three major groups of agents--inhibitors of PO, of prostanoids, and of protein biosynthesis--upon the development of the PO reaction was examined. When aminotriazole, a PO inhibitor, was added to the culture medium, the appearance of PO was suppressed in the monocytes. The cyclooxygenase blocker, indomethacin, however, did not influence the development of PO. Also the blockers of protein synthesis, puromycin, cycloheximide, and actinomycin D, did not affect the appearance of PO. The prostanoids released from the monocytes, ie, prostaglandin E and thromboxane B2, were determined by radioimmunoassay and showed a time sequence of secretion that corresponded to the appearance of PO in the cells: a marked increase within the first 24 hours with a substantial decrease thereafter. The presence of the PO inhibitors aminotriazole and sodium azide in the culture medium produced a suppression of prostanoid release from the monocytes comparable with that of indomethacin. The data suggest that the PO in the NE and ER of differentiating monocytes in vitro (1) is associated with arachidonic acid metabolism, and (2) is not formed by de novo protein synthesis but rather by an activation process.

scholarly journals The influence of albumin and calcium on human platelet arachidonic acid metabolism

Blood ◽  
1980 ◽  
Vol 55 (3) ◽  
pp. 418-423 ◽  
Author(s):  
MJ Stuart ◽  
JM Gerrard ◽  
JG White
Keyword(s):  
Arachidonic Acid ◽  
Acid Metabolism ◽  
Human Platelet ◽  
Arachidonic Acid Metabolism ◽  
Albumin Concentration ◽  
Arachidonic Acid Release ◽  
Acid Release ◽  
External Calcium ◽  
Platelet Thromboxane

Abstract The effects of in vitro changes in calcium and albumin on human platelet arachidonic acid metabolism were evaluated. Hypoalbuminemia enhanced the conversion of released 14C-arachidonic acid from prelabeled platelet phospholipids to the metabolites of the platelet cyclooxygenase and lipoxygenase pathways. This effect was, however, associated with a decreased release of arachidonic acid in the presence of hypoalbuminemia, such that the overall conversion of released 14C- arachidonic acid to platelet thromboxane B2 was similar in the presence of physiologic albumin concentration (3.5 g/dl) or at decreased albumin concentrations of 0.7 and 0.0 g/dl. External calcium was shown to be important for optimal platelet arachidonic acid release, with maximal release occurring at 1 mM calcium.

The molecular biology of mammalian arachidonic acid metabolism

1991 ◽  
Vol 260 (2) ◽  
pp. L13-L28 ◽  
Author(s):  
E. Sigal
Keyword(s):  
Arachidonic Acid ◽  
Acid Metabolism ◽  
Recombinant Dna ◽  
Biological Activities ◽  
Biological Effects ◽  
Arachidonic Acid Metabolism ◽  
Bioactive Metabolites ◽  
Wide Range

The metabolism of arachidonic acid by cyclooxygenase and lipoxygenase enzymes results in a wide range of oxidized products with potent biological activities. These metabolites, which include the prostaglandins and leukotrienes, have been implicated in the pathogenesis of a variety of inflammatory diseases. Research over the last decade has focused primarily on the elucidation of the chemical structure of the metabolites and their biological effects in vitro and in vivo. Recently, research on the enzymes that produce these bioactive metabolites through oxidization of arachidonic acid has intensified. Recombinant DNA techniques have enabled investigators to determine the nucleotide sequences for several of the enzymes in the arachidonic acid cascade. The resulting cDNAs are now being used to further investigate the biochemical and biological features of arachidonic acid metabolism. The purpose of this paper is to review how the cDNAs for these enzymes were obtained, what information they convey, and how they are being applied in current research.

Arachidonic acid metabolism and thyrotropin secretion in vitro

1984 ◽  
Vol 98 (1) ◽  
pp. 45-52 ◽  
Author(s):  
Pier Luigi Canonico ◽  
Carlos A. Valdenegro ◽  
Allan M. Judd ◽  
Robert M. Macleod
Keyword(s):  
Arachidonic Acid ◽  
Acid Metabolism ◽  
Arachidonic Acid Metabolism
Sign in / Sign up

Export Citation Format

Share Document